Cover Image

Comment on “Integrative Analysis of Ex Vivo Studies and Microarray Reveals the Novel Inhibitor Effects of Trehalose on the Pathogenesis of Pterygium”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Thiago Gonçalves dos Santos Martins
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Chemical Biology & Drug Design
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Synthesized Benzophenone Thiazole Hybrids Exhibited Ex Vivo and In Silico Anti‐Inflammatory Activity
by: Luiz Paulo Melchior de Oliveira Leão, et al.
Published: (2024)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
by: Nurul Alam Inayatsyah, et al.
Published: (2024)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
by: Ozge Kuyrukcu Ozturk, et al.
Published: (2026)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
by: Jingting Zeng, et al.
Published: (2025)

Exploring Flavonoids as Regulators of MMP‐2 and MMP‐9 in Cancer Pathogenesis
by: Ha Vy Thi Vo, et al.
Published: (2025)

Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis: A Computational and Experimental Study
by: Mariana Sant’Anna Pereira Nicolau, et al.
Published: (2025)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
by: Yi‐Fan Zhang, et al.
Published: (2024)

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent
by: Qingxin Liu, et al.
Published: (2025)

Chromone Derivatives as a Novel NOX4 Inhibitor: Design, Synthesis, and Regulation of ROS in Renal Fibroblast
by: Siming Wu, et al.
Published: (2024)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
by: Vijaykumar D. Nimbarte, et al.
Published: (2025)

Computationally Driven Exploration of Novel bis‐Thiadiazole Sulfonamides as Alzheimer's Enzyme Inhibitors: A DFT and Kinetic Perspective
by: Farman Ullah, et al.
Published: (2025)

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
by: Shiying Zhang, et al.
Published: (2025)

Novel Donepezil–Chalcone Hybrids as Potential Multifunctional Anti‐Alzheimer’s Disease Agents: Design, Synthesis, Computational Simulation, and In Vitro/In Vivo Biological Evaluation
by: Zhiqi Lin, et al.
Published: (2026)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
by: Kalyani R. Thombre, et al.
Published: (2026)

Identification of Autophagy‐Associated Molecular Signatures in Osteoarthritis Revealed by Integrative Multi‐Omics and Experimental Validation
by: Xiaoqing Wang, et al.
Published: (2026)

Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
by: Mei Liu, et al.
Published: (2024)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
by: Ayşen Işık, et al.
Published: (2024)

Biochemical and Structural Studies of Protein Tyrosine Phosphatase PTP‐PEST (PTPN12) in Search of Small Molecule Inhibitors
by: Delna Johnson, et al.
Published: (2025)

Comprehensive Analysis of NADH:Ubiquinone Oxidoreductase Subunit B3 in Gynecological Tumors and Identification of Its Natural Inhibitor Wedelolactone
by: Huiping Li, et al.
Published: (2024)

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology
by: Rameshwar S. Cheke, et al.
Published: (2025)

Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers
by: Aamir Mehmood, et al.
Published: (2024)

Semisynthetic p‐Coumaric Acid Derivatives as Lead Dual Inhibitors Against DPP‐IV and GSK‐3β for Antidiabetic Therapy
by: Heberth de Paula, et al.
Published: (2024)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
by: Gözde Sayar, et al.
Published: (2026)

Spacered With Tetrazole Oleanolic and Ursolic Indolo‐Acids Are Strong Inhibitors of α‐Glucosidase
by: Anastasiya V. Petrova, et al.
Published: (2025)

Network Pharmacology and Transcriptomic Analysis Reveal the Mechanism by Which Ginsenoside CK Remodels the Tumor Immune Microenvironment to Inhibit Liver Cancer Progression
by: Fangzhi Ye, et al.
Published: (2025)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
by: Vladislav Lobanov, et al.
Published: (2025)

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors
by: Rui Pereira, et al.
Published: (2026)

Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities
by: Yu Jiang, et al.
Published: (2025)

Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
by: Hualiang Shen, et al.
Published: (2025)

A Journey Around Boronic Acids: Sulfonyl Hydrazone‐Containing Derivatives as Carbonic Anhydrase Inhibitors
by: Deniz A. Anakök, et al.
Published: (2025)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
by: Jiayi Shen, et al.
Published: (2024)

A Comprehensive Review on the Advancements of Dual COX‐2/5‐LOX Inhibitors as Anti‐Inflammatory Drugs
by: Neetu Agrawal
Published: (2025)

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
by: Chung‐Ting Kuo, et al.
Published: (2026)

Anti‐Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells
by: Esraa A. Aidy, et al.
Published: (2026)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
by: Shreetama Bandyopadhayaya, et al.
Published: (2025)

Discovery of Novel Oxadiazole‐Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies
by: Venkatraman Hegde, et al.
Published: (2025)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
by: Yihao Liu, et al.
Published: (2026)

Design and Synthesis of 2‐Aminopyrazolpyrimidopyridone Derivatives as RET V 804 M and RET G 810 C Kinase Inhibitors
by: Jiayi Shen, et al.
Published: (2025)

Assessment of Antidiarrheal Activity of Fraxin in Chick: Synergistic Effects and Molecular Docking Study
by: Wahidul Alam, et al.
Published: (2026)

Network Pharmacology‐Based Analysis and In Vitro Experiments Validation Reveal Tormentic Acid Induces Apoptosis via PI3K / AKT / HSP90 Pathway in HepG2 Cells
by: Jingyang Lu, et al.
Published: (2026)